Le Lézard
Classified in: Mining industry, Health, Science and technology
Subject: TRADE SHOWS/SEMINARS/WEBINARS

Vivakor to Present at the Annual Energy Development Summit 2017 in Salt Lake City


LAS VEGAS, NV--(Marketwired - April 27, 2017) - Vivakor, Inc. (OTC PINK: VIVK) is pleased to announce that the company will be presenting at the Energy Development Summit being held May 3-4, 2017 at Grand America Hotel in Salt Lake City, UT. Matt Nicosia, Chairman and CEO, will be participating in a morning panel discussion on Capitalizing Energy Financing Strategies. Presentations will be conducted by noted figures in politics like the Gov. Gary Herbert (UT) and Matt Mead (WY), along with the Ambassador to Mexico Geronimo Gutierrez who will be part of a panel discussing Advancing Strategic Partnerships. In addition, such leaders in the energy space like Jack Gerard, Pres/CEO of the American Petroleum Institute (API) will also be speaking amongst many others. Two full days of presentations and breakout sessions by the leaders in the Energy Sector in Utah. Thousands of attendees from around the world

Vivakor, Inc. procures and develops revenue producing assets around the world. These holdings include intellectual properties that are proprietary and largely disruptive while centered principally in the natural resources sector. Vivakor is essentially an asset acquisition company focused specifically on energy related projects across the globe, its patented, oil extraction technology and methodology operates in a production capacity in Utah. Unique to the Company is a mobile rapid deployment, global capability for remediation and reclamation of contaminated soil created generally due to oil. The Company also utilizes a thermal technology for extraction of metals from sand-based ore in the Southwest US. Since 2013, the Company has effectively captured non-visible precious metals and rare earth minerals through its proprietary technology and method for processing the ore.

ABOUT VIVAKOR, INC.

For more information, please visit www.vivakor.com

FORWARD-LOOKING STATEMENTS

This news release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including economic slowdown affecting companies, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors may be incorporated herein by reference. Forward-looking statements may be identified but not limited by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: